Amyotrophic lateral sclerosis: new era, new challenges

Affiliations

¹ Department of Neurology, Peking University Third Hospital, Beijing 100191, China; Beijing Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Beijing, China.
² Department of Neurology, Peking University Third Hospital, Beijing 100191, China; Beijing Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Beijing, China. Electronic address: dsfan2010@aliyun.com.

Comment

Lu Tang et al. Lancet Neurol. 2022 May.

. 2022 May;21(5):400-401.

doi: 10.1016/S1474-4422(22)00084-9. Epub 2022 Mar 22.

¹ Department of Neurology, Peking University Third Hospital, Beijing 100191, China; Beijing Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Beijing, China.
² Department of Neurology, Peking University Third Hospital, Beijing 100191, China; Beijing Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Beijing, China. Electronic address: dsfan2010@aliyun.com.

No abstract available

Conflict of interest statement

We declare no competing interests.

Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis.
Goutman SA, Hardiman O, Al-Chalabi A, Chió A, Savelieff MG, Kiernan MC, Feldman EL. Goutman SA, et al. Lancet Neurol. 2022 May;21(5):480-493. doi: 10.1016/S1474-4422(21)00465-8. Epub 2022 Mar 22. Lancet Neurol. 2022. PMID: 35334233 Free PMC article. Review.
Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis.
Goutman SA, Hardiman O, Al-Chalabi A, Chió A, Savelieff MG, Kiernan MC, Feldman EL. Goutman SA, et al. Lancet Neurol. 2022 May;21(5):465-479. doi: 10.1016/S1474-4422(21)00414-2. Epub 2022 Mar 22. Lancet Neurol. 2022. PMID: 35334234 Free PMC article. Review.